Search - tctmd.com

Displaying 321 - 340 of 411

Sort: Relevancy | Date

Presentation ICI 2014

Cerebral Protection During TAVR Study Design and Results of the DEFLECT II Trial

Presenter: P. R. Stella

December 14, 2014

News Conference News TCT 2014

Meta-analyses Explore Cerebrovascular Protection, TIA and Stroke Risk with Carotid Stenting

September 22, 2014

Presentation TCT 2014

Carotid Artery Stenting with Double Cerebral Embolic Protection in Symptomatic Patients

Presenter: Ferdinando Varbella

September 16, 2014

News Conference News TCT 2014

Capture Devices Hold Promise for Decreasing TAVR-Related Stroke

September 15, 2014

Presentation TCT 2014

TCT 548: Proximal Occlusion Versus Distal Filter for Cerebral Protection During Carotid Stenting: A Meta-analysis of MRI Studies

Presenter: Leo Nelson Hopkins, Sriram S. Iyer, Zvonimir Krajcer, Salvatore Cassese, MD

September 13, 2014

Presentation TCT 2014

CLEAN-TAVI: A Prospective, Randomized Trial of Cerebral Embolic Protection in High-Risk Patients with Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement

Presenter: Patrick W. Serruys, David J. Cohen, Axel Linke

September 13, 2014

News Industry News

Cerebral Protection Device Reduces Brain Injury Risk in Patients with Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement

September 13, 2014

News Daily News

颈动脉支架置入术中首选近端栓塞保护

August 07, 2014

News Daily News

Proximal May Be Preferred Form of Embolic Protection in Carotid Stenting

August 07, 2014

News Daily News

La Protección Embólica Proximal podría ser la Fórmula Preferida en la Implantación de Stents Carotídeos

August 07, 2014

Presentation TVT 2014

A Critical Analysis of Present Data on Cerebral Protection after TAVR

Presenter: Axel Linke

June 07, 2014

Presentation TVT 2014

Why Cerebral Protection after TAVR Will Become the Standard of Care

Presenter: Eberhard Grube

June 07, 2014

Presentation TVT 2014

Why Cerebral Protection after TAVR Will be Used Sparingly (if at all) in the Future

Presenter: Ganesh Manoharan

June 07, 2014

Presentation TVT 2014

Has Stroke Frequency Declined After TAVR?

Presenter: Nicolas M. van Mieghem

June 07, 2014

Presentation TVT 2014

Perspectives from the US CoreValve Trials

Presenter: Jeffrey J. Popma

June 07, 2014

Presentation TVT 2014

Perspectives from the PARTNER Trials

Presenter: Susheel Kodali

June 07, 2014

Presentation TVT 2014

Incidence, Timing, Predictors (New Onset AF, Postdilatation, etc.), and Clinical Impact

Presenter: Samir R. Kapadia

June 07, 2014

Presentation TVT 2014

Technology Overview and Clinical Trial Status (DEFLECT I and Other Trials)

Presenter: Alexandra J. Lansky

June 06, 2014

Presentation TVT 2014

Introduction to the US FDA-Approved Sentinel TAVR Safety and Efficacy Study

Presenter: Susheel Kodali

June 06, 2014

Presentation TVT 2014

Histo-Pathology Debris Analysis and Status of the MISTRAL C Randomized Trial

Presenter: Nicolas M. van Mieghem

June 06, 2014

Advertisement

Cerebral Protection During TAVR Study Design and Results of the DEFLECT II Trial

Meta-analyses Explore Cerebrovascular Protection, TIA and Stroke Risk with Carotid Stenting

Carotid Artery Stenting with Double Cerebral Embolic Protection in Symptomatic Patients

Capture Devices Hold Promise for Decreasing TAVR-Related Stroke

TCT 548: Proximal Occlusion Versus Distal Filter for Cerebral Protection During Carotid Stenting: A Meta-analysis of MRI Studies

CLEAN-TAVI: A Prospective, Randomized Trial of Cerebral Embolic Protection in High-Risk Patients with Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement

Cerebral Protection Device Reduces Brain Injury Risk in Patients with Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement

颈动脉支架置入术中首选近端栓塞保护

Proximal May Be Preferred Form of Embolic Protection in Carotid Stenting

La Protección Embólica Proximal podría ser la Fórmula Preferida en la Implantación de Stents Carotídeos

A Critical Analysis of Present Data on Cerebral Protection after TAVR

Why Cerebral Protection after TAVR Will Become the Standard of Care

Why Cerebral Protection after TAVR Will be Used Sparingly (if at all) in the Future

Has Stroke Frequency Declined After TAVR?

Perspectives from the US CoreValve Trials

Perspectives from the PARTNER Trials

Incidence, Timing, Predictors (New Onset AF, Postdilatation, etc.), and Clinical Impact

Technology Overview and Clinical Trial Status (DEFLECT I and Other Trials)

Introduction to the US FDA-Approved Sentinel TAVR Safety and Efficacy Study

Histo-Pathology Debris Analysis and Status of the MISTRAL C Randomized Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content